ARCHIVES

NCI Says Review Group Will Read Blueprint, Evaluate NCI Research

This article is from The Cancer Letter archive.

Vol. 24 No. 02 | January 16, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: NCAB to Hear Program Review, Reports On AIDs Monoclonal Antibodies, Cancer Research at Drew

November 25, 1983

In Brief: Fidler Wins BMS Cancer Research Award; Thomas Cech To Head Howard Hughs Inst.

April 2, 1999

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

July 27, 2012

Hawking Hearings Turn Up Difference Between Management, Staff At FDA

November 20, 1981

Bushes Restate Commitment to Dialogue

August 8, 2003

House Subcommittee Recommends $137.7 Million Increase For NCI

June 21, 1996